Literature only: animal allogeneic/syngeneic islets with immunosuppressants in diabetic mice, rats and NHPs; no studies with the product
“Instead, the applicant referenced multiple publications and one manuscript in the BLA submission that evaluated biological activity, local (liver) distribution, and the local (liver) safety of transplanted allogeneic or syngeneic islets in combination with various immunosuppressive agents in diabetic rodent (mice, rats) and nonhuman primate (NHP) models.”
✓ VerifiedFDA pharmacology/toxicology review, p. 2Source ↗
Why that model
Not stated in public reviews
Not reported in the public reviews. Reviewers summarise selectively, so this usually means it wasn't discussed publicly, not that it wasn't studied.
Reviewer's view of the efficacy data
Published literature gave overall support for mechanism of action and need for immunosuppression; supports approval
“Review of the nonclinical studies in the published literature provided overall support for the purported mechanism of action of LANTIDRA and the need for an immunosuppressive regimen. The nonclinical data support approval of the license application.”
✓ VerifiedFDA pharmacology/toxicology review, p. 26Source ↗
autologous cultured chondrocytes on porcine collagen membrane · Autologous chondrocytes
Analogous MACI (animal cells on same membrane) in critical-sized knee/stifle cartilage defects in rabbits and horses: improved repair vs membrane alone or empty defect